Hoel Sette

2.3k total citations · 1 hit paper
32 papers, 1.7k citations indexed

About

Hoel Sette is a scholar working on Hepatology, Epidemiology and Parasitology. According to data from OpenAlex, Hoel Sette has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 13 papers in Epidemiology and 8 papers in Parasitology. Recurrent topics in Hoel Sette's work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Hoel Sette is often cited by papers focused on Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Hoel Sette collaborates with scholars based in Brazil, United States and Switzerland. Hoel Sette's co-authors include Sharon Passe, Francesca J. Torriani, Franck Le Duff, Christine Katlama, Joseph Sasadeusz, Adriano Lazzarin, Giampiero Carosi, Juan González‐García, M. Rodríguez‐Torres and Joan Montaner and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Hoel Sette

32 papers receiving 1.6k citations

Hit Papers

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatiti... 2004 2026 2011 2018 2004 250 500 750

Peers

Hoel Sette
Comparison fields: 5 of 69
  • Hepatology 1.5k
  • Epidemiology 1.3k
  • Infectious Diseases 469
  • Surgery 86
  • Virology 72
Replace Ángela Camacho with:
Ángela Camacho Spain
Patrick Miailhes France
Gabriella Verucchi Italy
Joe Sasadeusz Australia
Mojca Matičič Slovenia
Denis Ouzan France
Maria de Medina United States
P Cadrobbi Italy
Carlton Meschievitz United States
John Fry United States
Ángela Camacho Spain View profile →
Citations per field, relative to Hoel Sette
Hoel Sette · 1×
Citations per year, relative to Hoel Sette
Hoel Sette · 1×

Countries citing papers authored by Hoel Sette

Since Specialization
Citations

This map shows the geographic impact of Hoel Sette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoel Sette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoel Sette more than expected).

Fields of papers citing papers by Hoel Sette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoel Sette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoel Sette. The network helps show where Hoel Sette may publish in the future.

Co-authorship network of co-authors of Hoel Sette

This figure shows the co-authorship network connecting the top 25 collaborators of Hoel Sette. A scholar is included among the top collaborators of Hoel Sette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoel Sette. Hoel Sette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 133
2 92
3 1
4 11
5 27
6 2
7 22
8
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients breakdown →
953
9 2
10 1
11 92
12
Estimated Prevalence of Viral Hepatitis in the General Population of the Municipality of São Paulo, Measured by a Serologic Survey of a Stratified, Randomized and Residence-Based Population.
113
13 8
14 32
15
Peritonite bacteriana espontanea
1
16
Praziquantel in the treatment of the hepatosplenic form of Schistosomiasis mansoni.
17
17
Serum antibody changes after chemotherapy of patients with schistosomiasis mansoni. A statistical analysis.
4
18
Serum antibody changes after repeated chemotherapic series in "parasitologically cured" patients with schistosomiasis mansoni.
5
19
Occurrence of hepatitis-associated-antigen (HAA) subdeterminants ad and ay in blood donors, acute and chronic liver disease.
1
20
Clinical trials with oral oxamniquine (UK 4271) for the treatment of mansonian schistosomiasis.
24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026